Haibo Zhu - Concepedia

Author

Haibo Zhu

Tianjin Medical University ORCID

Also Known As

H B Zhu, H Zhu, H. Zhu, Hai-Bo Zhu, Hai-bo Zhu, Haibo Zhu, Hai‑Bo Zhu, Zhu, Haibo

Publications

643

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University Tianjin First Center Hospital Nankai University Beijing Institute of Neurosurgery Beijing Tian Tan Hospital

About

Haibo Zhu is an author at Tianjin Medical University specializing in medicine, health sciences, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	163
2	Health Sciences	3	3	150
3	Immunology	3	3	61
4	Cellular Therapies	2	2	34
5	Hepatology	1	1	102

Haibo Zhu

Publications

493

Citations

H-Index

Page 1

	Year	Citations
In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis Guisheng Li, Wanglin Jiang, Jingwei Tian, Phytomedicine FibrosisHepatologyVivo Antifibrotic EffectsLiver PhysiologyPhysiology	2009	102
Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas Haibo Zhu, Jing Guo, Yutao Shen, Clinical Cancer Research	2018	59
CAR‑T 19 combined with reduced‑dose PD‑1 blockade therapy for treatment of refractory follicular lymphoma: A case report Jia Wang, Qi Deng, Yanyu Jiang, Oncology Letters	2019	41
RETRACTED: Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis Chunmei Li, Wanglin Jiang, Haibo Zhu, Pharmaceutical Biology	2011	39
Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury Xiang Xue, Ying Xiao, Haibo Zhu, Nephrology Dialysis Transplantation	2008	36
CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition Bin Li, Jianhua Cheng, Hongyun Wang, Journal of Translational Medicine	2019	27
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy Yifan Zhao, Xiaomei Zhang, Meng Zhang, Annals of Hematology Hematological MalignancyTranslational MedicineMedicineAcute Myeloid LeukemiaSevere Crs/icans	2024	27
Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy Haibo Zhu, Haobin Deng, Juan Mu, OncoTargets and Therapy	2021	26
The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma Haibo Zhu, Yazhou Miao, Yutao Shen, Journal of Translational Medicine	2019	21
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease Wenyi Lu, Yunxiong Wei, Yaqing Cao, Cancer Immunology Immunotherapy Cell TherapyImmunologyPathologyImmunotherapyHematological Malignancy	2021	21

Page 1